{
    "eid": "2-s2.0-85135732672",
    "title": "Peritonitis after exposure to biocontrol-agent fumes containing Talaromyces flavus: a case report in peritoneal dialysis patient",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Biocontrol agents",
        "Fungal peritonitis",
        "Non-marneffei Talaromyces",
        "Peritoneal dialysis",
        "Talaromyces flavus"
    ],
    "authors": [
        "Phanit Sookto",
        "Talerngsak Kanjanabuch",
        "Tamonwan Chamroensakchai",
        "Nisa Thongbor",
        "Somchai Eiam-Ong"
    ],
    "citedby-count": 0,
    "ref-count": 12,
    "ref-list": [
        "Characteristics and outcomes of fungal peritonitis in a modern North American cohort",
        "ISPD peritonitis recommendations: 2016 Update on prevention and treatment",
        "Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology",
        "ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment",
        "(1\u21923)-\u03b2-D-Glucan and galactomannan for a differentiation of chemical \u201cblack particles\u201d and fungal particles inside peritoneal dialysis tubing",
        "Promising effect of in-situ lyticase enzyme therapy on peritoneal dialysis catheter obstruction from acremonium fungal biofilm: A case report",
        "Morphology and distribution of Talaromyces flavus from soil and potential use as a biological control agent against plant pathogenic fungi",
        "Comparative degradation of oomycete, ascomycete, and basidiomycete cell walls by mycoparasitic and biocontrol fungi",
        "ISPD guidelines/recommendations peritoneal dialysis training",
        "ISPD position statement on reducing the risks of peritoneal dialysis-related infections",
        "The CARI guidelines: Evidence for peritonitis treatment and prophylaxis: treatment of peritoneal dialysis-associated fungal peritonitis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Ubon Ratchathani",
            "@id": "115838518",
            "affilname": "Sunpasitthiprasong Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/115838518",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "King Chulalongkorn Memorial Hospital Microbiological Laboratory",
        "Sunpasitthiprasong Hospital",
        "Thailand Science Research and Innovation Fund Chulalongkorn University CU_FRB65_hea",
        "Chulalongkorn University",
        "National Research Council of Thailand, Thailand"
    ]
}